Phase 1 Leukaemia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People older than 6 months of age.
- People whose cancer sample shows a high number of blast cells (at least 30% of cells are cancerous), which is needed to prepare the treatment used in this trial.
- People whose cancer cells have been tested and shown to carry certain markers — CD19, CD22, CD20, CD10, or CD123 — detected through standard lab testing.
- People whose general health and ability to function has been assessed as reasonably good (above a set threshold on a standard health scoring scale), with a life expectancy of more than 3 months.
- People whose heart, liver, kidneys, and bone marrow are functioning well enough to meet specific lab result thresholds set by the trial (confirm with trial site for exact values).
- People for whom a standard cell separation procedure would not be medically unsafe.
- People who are able to understand the trial and are willing to sign a written consent form (or whose parent or guardian can do so, where applicable).
Who may not be able to join:
- People with a serious illness or medical condition that would make it unsafe to follow the trial's treatment plan, including active infections that are not under control.
- People with an active bacterial, fungal, or viral infection that has not responded to appropriate treatment.
- People with a known diagnosis of HIV, hepatitis B, or hepatitis C.
- People who are pregnant or currently breastfeeding.
- People who have taken steroid medications (glucocorticoids) as a whole-body (systemic) treatment within the week before entering the trial.
- People who have previously received any gene therapy treatment.
- People whom the trial investigators determine may not be suitable or may not be able to follow the trial's requirements.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86 0755-86573763
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Safety of infusion; Clinical response
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.